Here’s How It Works

For the first time, Blueprint Diagnostics can accurately predict:

We use our advanced GigaAssay™ to look at all 5,886 known HER2+ mutations — not just a few. We measure how your specific genetics respond to each of the top drugs in real cells, not just in theory.

We’ll show you exactly which drugs won’t bind, won’t activate, and won’t help — so you can avoid wasted time, unnecessary side effects, and false hope.

If our biosimilar is a match, we’ll supply it directly to you or your provider. If not, we’ll let you know which drugs might be better — even if we don’t sell them.

Why This Matters

3 out of 4 cancer patients take drugs that won’t help them — and don’t know it.

Traditional treatments are based on averages, not you.

We believe you deserve better — starting with answers, and ending with medicine that fits.

We’re Not Just a Lab. We’re Your Advocate.

We’re beginning with:

 Breast Cancer — Specifically HER2+

Ready to Get Started?

If you or someone you love has HER2+ cancer, let’s begin with a simple step:  Find out what might actually work — and avoid what won’t.

Get Your Test Today